Corporate ActionJun 3, 2026, 10:59 PM
Jade Biosciences Prices Public Offering of 10M Shares at $15.00/Share
AI Summary
Jade Biosciences, Inc. announced the pricing of a public offering of 10,000,000 shares of its common stock at $15.00 per share, expecting to raise $150.0 million in gross proceeds. The company also granted underwriters a 30-day option to purchase up to an additional 1,500,000 shares. The net proceeds, combined with existing cash, will be used to fund clinical trials, preclinical studies, manufacturing, research and development, capital expenditures, working capital, and other general corporate purposes. The offering is anticipated to close on June 5, 2026.
Key Highlights
- Priced public offering of 10,000,000 shares of common stock.
- Shares sold at $15.00 per share.
- Expected gross proceeds of $150.0 million from the offering.
- Underwriters granted 30-day option to purchase up to 1,500,000 additional shares.
- Proceeds to fund clinical trials, preclinical studies, manufacturing, and R&D.
- Offering expected to close on June 5, 2026.
Price Impact
More from JBIO